YanLe Zhi

Dr. YanLe Zhi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

30 November 2019 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
FJFei Jiang
Fei Jiang
QHQinghua Hu
Qinghua Hu
ZZZhimin Zhang
Zhimin Zhang
HLHongmei Li
Hongmei Li
HLHuili Li
Huili Li
YCYadong Chen
Yadong Chen

18 July 2023 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
HCHui Chen
Hui Chen
WZWen-Jing Zhang
Wen-Jing Zhang
JKJiang-Bo Kong
Jiang-Bo Kong
YLYun Liu
Yun Liu
YZYanLe Zhi
YanLe Zhi
ZXZhi-Shen Xie
Zhi-Shen Xie

22 January 2026 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
ZWZhijie Wang
Zhijie Wang
HHHaiQi He
HaiQi He
JXJianwei Xu
Jianwei Xu
XLXiaotong Liao
Xiaotong Liao
JTJun Tan
Jun Tan
JCJianjun Chen
Jianjun Chen

9 September 2025 in ACS Omega
Verified
Journal Article
Open access
GXGuimin Xue
Guimin Xue
HFHao Feng
Hao Feng
XGXin-Xin Guo
Xin-Xin Guo
HPHao Pan
Hao Pan
YSYan-Jun Sun
Yan-Jun Sun
JXJin-Feng Xue
Jin-Feng Xue
Five novel naturally occurring diacetylenic spiroacetal enol ethers, named chracetylespienoles A-E (1-5), along with five known analogues (6-10), were isolated from the aerial part of Chrysanthemum indicum. A combination of extensive spectroscopy, chemical derivatization, DP4+ NMR analysis, and ECD calculations was employed to determine the new compounds' structures and assign their absolute configurations. The anti-inflammatory activity of 1-10 was determined by measuring their suppression on NO production in lipopolysaccharide (LPS)-mediated RAW 264.7 cells, and 8 showed the best NO production inhibitory activity with an IC50 value of 7.42 ± 0.87 μM. Furthermore, compound 8 downregulated the expression of iNOS and COX-2 proteins by inhibiting the MAPK and activating the Nrf2 signaling pathways, thereby suppressing inflammatory cascades.

18 June 2025 in Drug Development Research
Verified
Journal Article
Closed access
KDKun Du
Kun Du
YHYanan He
Yanan He
JFJinyang Fu
Jinyang Fu
GXGuimin Xue
Guimin Xue
ZZZhiqiang Zhang
Zhiqiang Zhang
YZYanLe Zhi
YanLe Zhi